Determinants of Lung Function, COPD, and Asthma

Marco Cicardi, Aleena Banerji
2011 · W2184164508
article OA: closed CC0 Metadata only
View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-08-29 ⓘ

The provided text contains references to hereditary angioedema guidelines and does not contain an abstract or findings related to lung function, COPD, asthma, endometriosis, or adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

n engl j med 364;1 nejm.org january 6, 2011 86 replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Transfusion 2009;49: 1987-95. 2. Bowen T, Cicardi M, Farkas H, Bork K, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010;6:24. 3. Longhurst HJ, Farkas H, Craig T, et al. HAE international home therapy consensus document. Allergy Asthma Clin Immunol 2010;6:22.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (6)

Source provenance

openalex
last seen: 2026-05-10T10:38:40.447481+00:00
License: CC0 · commercial use OK